ENLAY(ENLAY)
ENLAY
No analyst ratings available
No analyst price targets available for ENLAY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $83.05B | $84.41B | $86.09B | $82.14B | $88.27B |
| Low | $74.61B | $69.60B | $77.35B | $73.79B | $79.30B |
| High | $101.63B | $112.63B | $105.35B | $100.51B | $108.02B |
| EBITDA Avg | $17.64B | $17.92B | $18.28B | $17.44B | $18.74B |
| Low | $15.84B | $14.78B | $16.42B | $15.67B | $16.84B |
| High | $21.58B | $23.92B | $22.37B | $21.34B | $22.94B |
| EBIT Avg | $10.97B | $11.15B | $11.37B | $10.85B | $11.66B |
| Low | $9.85B | $9.19B | $10.22B | $9.75B | $10.47B |
| High | $13.42B | $14.88B | $13.91B | $13.27B | $14.27B |
| Net Income Avg | $7.88B | $8.21B | $8.68B | $8.76B | $8.90B |
| Low | $6.84B | $7.13B | $7.54B | $7.60B | $7.72B |
| High | $10.17B | $10.60B | $11.21B | $11.31B | $11.49B |
| EPS Avg | $0.73 | $0.76 | $0.80 | $0.81 | $0.82 |
| Low | $0.63 | $0.66 | $0.70 | $0.70 | $0.71 |
| High | $0.94 | $0.98 | $1.03 | $1.04 | $1.06 |
| Analysts (Rev / EPS) | 11 / 1 | 21 / 1 | 18 / 1 | 10 / 1 | 10 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $22.42B | $27.35B |
| Low | $20.44B | $24.93B |
| High | $24.41B | $29.77B |
| EBITDA Avg | $4.76B | $5.81B |
| Low | $4.34B | $5.29B |
| High | $5.18B | $6.32B |
| EBIT Avg | $2.96B | $3.61B |
| Low | $2.70B | $3.29B |
| High | $3.22B | $3.93B |
| Net Income Avg | $1.90B | $1.83B |
| Low | $1.68B | $1.62B |
| High | $2.12B | $2.04B |
| EPS Avg | $0.18 | $0.18 |
| Low | $0.16 | $0.16 |
| High | $0.21 | $0.20 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 |